Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 11.00
-0.50 (-4.35%)
Feb 21, 2025, 3:53 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 38.09 million as of February 21, 2025. Its market cap has decreased by -17.14% in one year.
Market Cap
38.09M
Enterprise Value
43.57M
Revenue
1.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 38.09M, a decrease of -41.02%. That is a compound annual growth rate of -8.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |